Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pressure Biosciences (OP: PBIO )

0.7500 -0.0999 (-11.75%)
Streaming Delayed Price Updated: 3:49 PM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Pressure Biosciences

< Previous 1 2 Next >
Oil and Water Don't Mix, But This Company - Armed with Newly Awarded Patents and Proprietary Knowhow - Wants to Change That
Photo by Sharon Pittaway on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
Pressure BioSciences' BaroFold Platform Unleashes Hidden Growth Engine as Strong Demand for Protein Therapeutics Leverages PBI's Protein Refolding Technology
South Easton, MA, November 4, 2021 – Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale... 
Via Benzinga
Boston Named World's Top Biotech Hub as the City's Leading Biotech Companies Continue to Make Major Breakthroughs
Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
Via Benzinga
Top Astaxanthin Producers Turning to Pressure BioSciences to Increase Quality and Scale Production of World's Most Potent Antioxidant
Image provided by Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of... 
Via Benzinga
Pressure BioSciences New Eco-Friendly Agrochem Subsidiary Receives Over $1,000,000 in Orders in First Month of Operations
PBI Agrochem Integration into the Sales Channels of Its Planned Asset Acquisition of a Global, ... 
Via Benzinga
Pressure BioSciences Announces Forward Integration Plans for Ultra Shear Technology Demonstration and Toll Manufacturing Partnerships on U.S. West and East Coasts
Company Flooded with Opportunities to Demo Breakthrough UST Nanoemulsion Benefits and Serve Toll Production Demand in Pharmaceutical, Nutraceutical, and Personal Care Applications... 
Via Benzinga
Pressure BioSciences Partners with Academic and Industry Leaders to Revolutionize Food, Wellness and Biomedical Spaces
Image Provided By Pixabay Pressure BioSciences, Inc. (OTCQB: PBIO), the pioneer behind innovative, broadly applicable pressure-based technologies, has been aggressively pursuing... 
Via Benzinga
Pressure BioSciences, Inc. Reports Escalating Quarterly Revenue, Major Progress in Key Platform Technologies, and Formation of Eco-Friendly Agrochem Subsidiary that Already Posted Over $1 Million in Orders
Image Provided By Pexels... 
Via Benzinga
Pressure Biosciences Partners with Academic and Industry Leaders to Revolutionize Food, Wellness and Biomedical Spaces
Image Provided By Pixabay Pressure Biosciences, Inc. (OTCQB: PBIO), the pioneer behind innovative, broadly applicable pressure-based technology, has been aggressively pursuing... 
Via Benzinga
Pressure BioSciences Reports Strong 2nd Quarter Financial and Business Results; Looks Forward to an Even Stronger 2nd Half of 2021
Image Provided By Pixabay Pressure BioSciences, ... 
Via Benzinga
EXCLUSIVE: Pressure BioSciences Wins $1M Purchase Order For Agrochem Products
Pressure BioSciences Inc's (OTC: PBIO) agrochemicals subsidiary PBI Agrochem Inc has received initial purchase orders for over $1 million of eco-friendly... 
Via Benzinga
Patents, Partnerships, and Acquisitions Propel Pressure BioSciences Toward NASDAQ or NYSE Uplisting in 2021
Image Provided By Unsplash Investors on the lookout for the next big growth opportu... 
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
These OTC Securities Had the Most Trading Activity in July
Photo by Federico Beccari on Unsplash In July, O... 
Via Benzinga
Pressure BioSciences Unveils Aggressive Growth Plan and Goals for Second Half 2021; Company Marches Toward UST Commercial Release, Up-listing, and Profitability
Company’s Strong First Half 2021 Viewed as Launch Pad for Accelerating Second Half and Growth Trajectory, Propelled by Multiple Platform Technologies Building Market... 
Via Benzinga
Pressure BioSciences Nanoemulsion Platform Will Bring More Effective, More Shelf-Stable CBD-Infused Beverages to the Market by End of 2021
Image Provided By Pixabay CBD-infused beverages... 
Via Benzinga
New Ultra Shear Technology for Nanoemulsions Will Transform Multiple Large Markets; Latest Breakthrough From Pressure BioSciences
Photo by ThisIsEngineering from Pexels The leading developer of high-pressure-based platform technologies for life sciences applications worldwide, Pressure... 
Via Benzinga
Water-Soluble CBD With One Year Stability Has Been Achieved By Pressure BioSciences' Technology Representing 'Explosive Growth Opportunity'
A life sciences company Pressure BioSciences, Inc. (OTCQB: 
Via Benzinga
An Antioxidant 6,000x Stronger Than Vitamin C Will Soon Be Available in Infused Beverage and Topical Treatment Form
Image Provided By PXFuel Astaxanthin, a natural red pigmentation found in algae and crustaceans, has been a focus of research for the past few years as studies reveal how much... 
Via Benzinga
Pressure BioSciences Novel UST™ Platform Delivers Breakthrough Nanoemulsion Processing for One of the World's Most Potent Antioxidants - Astaxanthin
Unprecedentedly Tiny, Uniform, and Stable Nanoemulsified Oil Droplets Containing Astaxanthin Expected to Significantly Increase Oral and Topical Absorption of this... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.